VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious ...
The lowered pricing structure is now available for 101.82 EUR per bottle at pharmacies throughout Finland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharma ...
Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results